567 related articles for article (PubMed ID: 24603121)
1. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
Park IH; Lin J; Choi JE; Shin JS
Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
[TBL] [Abstract][Full Text] [Related]
2. Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.
Park IH; Youn JH; Choi IH; Nahm MH; Kim SJ; Shin JS
Infect Immun; 2005 Oct; 73(10):6399-406. PubMed ID: 16177311
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies.
Moe GR; Dave A; Granoff DM
Mol Immunol; 2006 Mar; 43(9):1424-31. PubMed ID: 16140379
[TBL] [Abstract][Full Text] [Related]
4. Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.
Tsang RS; Zollinger WD
Clin Diagn Lab Immunol; 2005 Jan; 12(1):152-6. PubMed ID: 15643000
[TBL] [Abstract][Full Text] [Related]
5. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.
Shin JS; Lin JS; Anderson PW; Insel RA; Nahm MH
Infect Immun; 2001 May; 69(5):3335-42. PubMed ID: 11292756
[TBL] [Abstract][Full Text] [Related]
7. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.
Azmi FH; Lucas AH; Raff HV; Granoff DM
Infect Immun; 1994 May; 62(5):1776-86. PubMed ID: 8168940
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
9. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
Pon RA; Lussier M; Yang QL; Jennings HJ
J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
[TBL] [Abstract][Full Text] [Related]
10. Peptide mimotopes of Neisseria meningitidis group B capsular polysaccharide.
Park I; Choi IH; Kim SJ; Shin JS
Yonsei Med J; 2004 Aug; 45(4):755-8. PubMed ID: 15344223
[TBL] [Abstract][Full Text] [Related]
11. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1.
Jennings HJ; Gamian A; Michon F; Ashton FE
J Immunol; 1989 May; 142(10):3585-91. PubMed ID: 2469720
[TBL] [Abstract][Full Text] [Related]
12. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?
Stein DM; Robbins J; Miller MA; Lin FY; Schneerson R
Vaccine; 2006 Jan; 24(3):221-8. PubMed ID: 16125824
[TBL] [Abstract][Full Text] [Related]
13. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
Rubinstein LJ; Stein KE
J Immunol; 1988 Dec; 141(12):4357-62. PubMed ID: 3143763
[TBL] [Abstract][Full Text] [Related]
14. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
Prinz DM; Smithson SL; Westerink MA
J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
[TBL] [Abstract][Full Text] [Related]
15. Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.
Moe GR; Bhandari TS; Flitter BA
J Immunol; 2009 May; 182(10):6610-7. PubMed ID: 19414816
[TBL] [Abstract][Full Text] [Related]
16. Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay.
Findlow J; Holland A; Martin D; Oster P; Balmer P; Borrow R
Clin Vaccine Immunol; 2007 May; 14(5):556-61. PubMed ID: 17344344
[TBL] [Abstract][Full Text] [Related]
17. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
Colino J; Outschoorn I
Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of monoclonal antibodies to group variant capsular polysaccharide of Neisseria meningitidis: recurrent heavy chains and alternative light chain partners.
Berry JD; Boese DJ; Law DK; Zollinger WD; Tsang RS
Mol Immunol; 2005 Feb; 42(3):335-44. PubMed ID: 15589322
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of a new monoclonal antibody against Neisseria meningitidis: study of the cross-reactivity with different bacterial genera.
De Gaspari EN
Hybridoma; 2000 Dec; 19(6):445-53. PubMed ID: 11152396
[TBL] [Abstract][Full Text] [Related]
20. Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.
Robbins JB; Schneerson R; Xie G; Hanson LÅ; Miller MA
Proc Natl Acad Sci U S A; 2011 Nov; 108(44):17871-5. PubMed ID: 22025709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
